Regression of left ventricular hypertrophy from systemic hypertension by enalapril

The American Journal of Cardiology

Volumn 53, Issue 8, 1984, Pages 1044-1049

  Nakashima, Yoshiyuki ^a   Fouad, Fetnat M ^a   Tarazi, Robert C ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENALAPRIL; ENALAPRIL MALEATE; RADIOISOTOPE;

BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; CLINICAL ARTICLE; DIAGNOSIS; DRUG THERAPY; ECHOCARDIOGRAPHY; HEART; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; M MODE ECHOCARDIOGRAPHY; ORAL DRUG ADMINISTRATION; RADIOISOTOPE VENTRICULOGRAPHY; SCINTIGRAPHY; THERAPY;

ADULT; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; CARDIOMEGALY; DIPEPTIDES; ENALAPRIL; EPINEPHRINE; FEMALE; HEMODYNAMICS; HUMAN; HYPERTENSION; MALE; MIDDLE AGE; NOREPINEPHRINE; RENIN;

EID: 0021365968     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9149(84)90634-9     Document Type: Article

References (33)

1. Is arterial pressure the sole factor responsible for hypertensive cardiac hypertrophy
2. Cardiac hypertrophy in spontaneously hypertensive rats
3. Regression of myocardial hypertrophy: conditions and sequelae of reversal in hypertensive heart disease
4. Effect of blood pressure control on LV hypertrophy and function in hypertension (abstr)
5. Reversal of left ventricular hypertrophy in hypertensive patients treated with methyldopa
6. Factors influencing cardiac hypertrophy in hypertensive patients
7. Cardiac muscle mass during vasodilation therapy of hypertension
8. Increases and decreases in ventricular septal thickness during diuretic therapy
9. Regression of myocardial hypertrophy and influence of adrenergic system
10. Hemodynamics of orally-active converting enzyme inhibitor (SQ 14225) in hypertensive patients
11. Antihypertensive effects of MK-421 hemodynamic and humoral correlates (abstr)
12. Effect of converting enzyme inhibitor (SQ14225) on myocardial hypertrophy in spontaneously hypertensive rats
13. Relation of plasma to interstitial fluid volume in essential hypertension
14. A reappraisal of the diagnostic criteria for primary aldosteronism
15. Automated computer program for radionuclide cardiac output determination
16. Evaluation of ventricular function by radioisotope technique
17. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements
18. Problems in echocardiographic volume determinations echocardiographic-angiographic correlations in the presence or absence of asynergy
19. Determinants of LV hypertrophy and function in hypertensive patients an echocardiographic study
20. Noninvasive assessment of load reduction in patients with asymptomatic aortic regurgitation
21. max, systolic P/V ratio and ejection fraction (abstr)
22. Noninvasive measurement of cardiopulmonary blood volume: evaluation of the centroid method
23. Cardiac function and myocardial contractility: a perspective
24. Reversal of left ventricular hypertrophy by antihypertensive therapy
25. Reversal of left ventricular hypertrophy with Captopril (abstr)
26. Left ventricular mass and function before and after antihypertensive treatment
27. Angiotensin and myocardial protein synthesis
28. Cardiac pumping ability following reversal of hypertrophy and hypertension in spontaneously hypertensive rats
29. Regression of LV hypertrophy in two-kidney, one clip Goidblatt hypertension
30. Favorable effects of therapy on cardiac performance in spontaneously hypertensive rats
31. Left ventricular hypertrophy: relationship of anatomic, echocardiographic and electrocardiographic findings